DTC(Direct-To-Consumer) 유전자 검사 시장 : 세계 산업 규모, 동향, 기회, 예측, 검사 유형별, 기술별, 샘플별, 유통 채널별, 지역별, 경쟁별(2019-2029년)
Direct-To-Consumer Genetic Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type, By Technology, By Sample, By Distribution Channel, By Region and Competition, 2019-2029F
상품코드 : 1463898
리서치사 : TechSci Research
발행일 : 2024년 04월
페이지 정보 : 영문 187 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,500 ₩ 6,513,000
Unprintable PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.
US $ 5,500 ₩ 7,960,000
PDF and Excel (Multi-User License) help
PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.
US $ 8,000 ₩ 11,579,000
PDF and Excel (Custom Research License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

세계의 DTC(Direct-To-Consumer) 유전자 검사 시장은 2023년에 15억 달러로 평가되며, 2029년 CAGR은 8.45%로, 예측 기간 중 눈부신 성장을 예측하고 있습니다.

DTC(Direct-to-Consumer) 유전자 검사 시장은 의료와 소비자 유전체학이 교차하는 역동적이고 빠르게 발전하는 분야로, DTC(Direct-to-Consumer) 유전자 검사는 의료 전문가의 개입 없이 개인이 자신에 대한 유전자 정보에 직접 접근할 수 있습니다.

DTC(Direct-To-Consumer) 유전자 검사 시장의 핵심은 자신의 유전적 체질과 건강, 가계, 형질에 미치는 영향에 관심이 있는 개인에게 제공하는 접근성입니다. 소비자는 온라인으로 검사 키트를 주문하고 집에서 수령한 후 DNA 샘플(보통 타액)을 제공하고 검사 회사에 샘플을 반송합니다. 그런 다음 검사 회사는 DNA를 분석하고 개인의 유전 정보의 다양한 측면에 대한 보고서를 작성합니다. 시장의 주요 촉진요인 중 하나는 건강 상태에 대한 유전적 소인을 이해하는 데 대한 관심이 증가하고 있으며, DTC(Direct-To-Consumer) 유전자 검사 회사는 특정 암, 심혈관 질환, 유전성 질환과 같은 증상에 대한 개인의 유전적 위험에 대한 인사이트을 제공합니다. 이 정보는 소비자가 자신의 라이프스타일, 의료 및 예방 조치에 대한 정보에 입각한 결정을 내릴 수 있도록 도와줍니다. 조상 유전자 검사는 개인이 자신의 유전적 유산을 탐색하고 가족 역사에 대한 정보를 발견할 수 있는 인기 있는 기능이 되고 있습니다. 유전체학의 기술 발전, 특히 DNA 시퀀싱과 데이터 분석의 발전은 DTC(Direct-To-Consumer) 유전자 검사 시장 확대에 더욱 중요한 역할을 하고 있습니다. 유전자 검사 결과의 정확성과 깊이가 향상됨에 따라 시장의 신뢰성과 매력도가 높아졌습니다.

이 시장은 기존 기업, 신생 기업, 유명 소비자 유전체학 브랜드 등 다양한 업체들이 진입하고 있는 것이 특징입니다. 이들 업체들은 대부분 특정 건강 위험 평가, 상세한 가계도, 형질 분석과 같은 고유한 기능을 제공함으로써 차별화를 꾀하고 있습니다. 데이터 공유 및 공동연구를 위한 연구기관 및 제약사와의 제휴는 시장의 역동성에 기여하고 있습니다.

DTC(Direct-To-Consumer) 유전자 검사 시장은 여러 가지 도전과 윤리적 고려사항에 직면해 있습니다. 유전자 데이터 처리와 관련된 프라이버시 문제, 기밀 정보의 악용 가능성, 검사 결과의 정확성 등이 문제시되고 있으며, DTC 모델에는 유전 상담이 없기 때문에 소비자에게 복잡한 유전 정보를 적절하게 해석하고 전달하는 것에 대한 의문이 제기되고 있습니다.

주요 시장 성장 촉진요인

개인화된 건강정보에 대한 소비자 수요

주요 시장 과제

프라이버시 및 보안에 대한 우려

결과의 정확성 및 해석

규제 및 윤리적 고려사항

유전상담과 사전 동의

주요 시장 동향

검사 제공 및 서비스 확대

원격의료와 원격상담

부문별 인사이트

검사 유형별 인사이트

기술별 인사이트

지역별 인사이트

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 세계의 DTC(Direct-To-Consumer) 유전자 검사 시장 전망

제5장 아시아태평양의 DTC(Direct-To-Consumer) 유전자 검사 시장 전망

제6장 유럽의 DTC(Direct-To-Consumer) 유전자 검사 시장 전망

제7장 북미의 DTC(Direct-To-Consumer) 유전자 검사 시장 전망

제8장 남미의 DTC(Direct-To-Consumer) 유전자 검사 시장 전망

제9장 중동 및 아프리카의 DTC(Direct-To-Consumer) 유전자 검사 시장 전망

제10장 시장 역학

제11장 시장 동향과 개발

제12장 세계의 DTC(Direct-To-Consumer) 유전자 검사 시장 : SWOT 분석

제13장 Porter's Five Forces 분석

제14장 경쟁 구도

제15장 전략적 제안

제16장 TechSci Research 소개·면책사항

KSA
영문 목차

영문목차

Global Direct-To-Consumer (DTC) Genetic Testing Market wasvalued at USD 1.50 Billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.45% through 2029. The Direct-to-Consumer (DTC) Genetic Testing Market is a dynamic and rapidly evolving sector at the intersection of healthcare and consumer genomics. DTC genetic testing involves individuals directly accessing genetic information about themselves without the involvement of healthcare professionals.

At the core of the DTC Genetic Testing Market is the accessibility it offers to individuals who are curious about their genetic makeup and its implications for health, ancestry, and traits. Consumers can order testing kits online, receive them at home, provide a DNA sample (usually through saliva), and return the sample to the testing company. The company then analyzes the DNA to generate reports on various aspects of the individual's genetic information. One of the key drivers of the market is the rising interest in understanding one's genetic predispositions for health conditions. DTC genetic testing companies provide insights into an individual's genetic risk for conditions such as certain types of cancer, cardiovascular diseases, and hereditary conditions. This information empowers consumers to make informed decisions about their lifestyle, healthcare, and preventive measures. Ancestry testing has become a popular feature, allowing individuals to explore their genetic heritage and discover information about their family history. Technological advancements in genomics, particularly in DNA sequencing and data analysis, have further played a crucial role in the expansion of the DTC Genetic Testing Market. Improvements in the accuracy and depth of genetic testing results contribute to the market's credibility and appeal.

The market is characterized by a diverse range of players, including established companies, startups, and well-known consumer genomics brands. These companies often differentiate themselves by offering unique features such as specific health risk assessments, detailed ancestry reports, or traits analysis. Partnerships with research institutions and pharmaceutical companies for data sharing and collaborative studies contribute to the market's dynamism.

The DTC Genetic Testing Market also faces challenges and ethical considerations. Privacy concerns related to the handling of genetic data, the potential misuse of sensitive information, and the accuracy of test results are subjects of scrutiny. The lack of genetic counseling in the DTC model raises questions about the appropriate interpretation and communication of complex genetic information to consumers.

Key Market Drivers

Consumer Demand for Personalized Health Insights

Consumer demand for personalized health insights stands as the driving force behind the rapid growth and evolution of the Direct-to-Consumer (DTC) Genetic Testing Market. This demand reflects a paradigm shift in healthcare, where individuals are increasingly taking proactive steps to gain a deeper understanding of their genetic makeup and its implications for their well-being. At the core of this driver is the human desire for knowledge-specifically, knowledge about one's own genetic information and its potential impact on health. People are inherently curious about their predispositions to various health conditions, the likelihood of developing certain diseases, and insights into their overall genetic health profile. DTC genetic testing addresses this curiosity by providing individuals direct access to information encoded in their DNA without the need for intermediary healthcare professionals.

The appeal of personalized health insights lies in the empowerment it offers to consumers. Armed with knowledge about their genetic risk factors, individuals can make informed decisions about their lifestyle, health management, and preventive measures. For instance, if a person learns about a heightened genetic susceptibility to a specific condition, they may choose to adopt lifestyle changes, undergo more frequent screenings, or consult with healthcare professionals for targeted preventive strategies. The growing emphasis on preventive healthcare aligns with the demand for personalized genetic insights. Consumers recognize that understanding their genetic predispositions allows for early intervention and proactive measures to mitigate potential health risks. This shift toward a preventive healthcare mindset is reshaping the healthcare landscape, with individuals seeking to leverage genetic information to optimize their health and well-being.

The COVID-19 pandemic has further highlighted the importance of accessible and convenient healthcare services. With lockdowns and restrictions limiting physical interactions, consumers turned to DTC genetic testing as a viable option for gaining health insights from the safety of their homes. The pandemic accelerated the adoption of remote healthcare solutions, and DTC genetic testing emerged as a resilient and adaptable option for individuals seeking health information during challenging times.

Key Market Challenges

Privacy and Security Concerns

Privacy and security concerns pose significant challenges for the Direct-to-Consumer (DTC) Genetic Testing Market. The inherent sensitivity of genetic data raises fears about potential breaches, unauthorized access, and misuse. Consumers worry about the protection of their most personal information. Safeguarding genetic data against cyber threats and ensuring compliance with data protection regulations are paramount. Companies in the DTC genetic testing space must invest in robust security measures, transparent privacy policies, and clear communication to build and maintain consumer trust. Addressing these concerns is essential for the sustainable growth of the market and fostering a secure environment for individuals to explore their genetic information.

Accuracy and Interpretation of Results

The challenge of accuracy and interpretation of results in the Direct-to-Consumer (DTC) Genetic Testing Market stems from the complexity of genetic data and the evolving nature of scientific knowledge. Variability in testing methodologies can lead to discrepancies, and the intricate nature of genetic information demands precision. Ensuring that consumers receive reliable and meaningful insights requires continuous efforts to enhance testing accuracy and improve result interpretation. Striking a balance between providing comprehensive genetic information and maintaining precision is essential to address this challenge and instill confidence in consumers regarding the reliability of their DTC genetic testing outcomes.

Regulatory and Ethical Considerations

Regulatory and ethical considerations pose significant challenges for the Direct-to-Consumer (DTC) Genetic Testing Market. The dynamic regulatory landscape requires companies to navigate evolving frameworks while ensuring compliance and innovation. Ethical concerns revolve around responsible use of genetic information, potential psychological impacts on consumers, and the need for informed consent. Striking a balance between promoting innovation, protecting consumers, and upholding ethical standards is a delicate challenge. Companies must actively engage in transparent communication, adhere to evolving regulatory requirements, and establish ethical guidelines to address these challenges and foster a trustworthy environment for consumers exploring DTC genetic testing services.

Genetic Counseling and Informed Consent

Genetic counseling and obtaining informed consent present significant challenges for the Direct-to-Consumer (DTC) Genetic Testing Market. The absence of direct, in-person genetic counseling within the DTC model raises concerns regarding consumers' capacity to comprehend intricate genetic information and the potential health implications. Ensuring sufficient support and securing informed consent emerge as critical obstacles, particularly given the nuanced nature of genetic data. Balancing accessibility with the necessity for comprehensive understanding presents a formidable challenge. Addressing this challenge entails developing effective methods for providing genetic counseling remotely, thereby empowering consumers with the knowledge required to make informed decisions about their health based on the results of DTC genetic testing.

Key Market Trends

Expanded Test Offerings and Services

The trend of expanded test offerings and services in the Direct-to-Consumer (DTC) Genetic Testing Market signifies a shift beyond traditional health-related insights. Companies are diversifying their portfolios to include a broader range of genetic tests, such as ancestry testing, trait analysis, and wellness assessments. This expansion provides consumers with a more comprehensive understanding of their genetic makeup, catering to diverse interests and preferences. By offering a spectrum of tests, DTC genetic testing services aim to engage a wider audience and meet the evolving demands of consumers who seek a holistic view of their genetic information, extending beyond medical implications to encompass various aspects of personal identity and well-being.

Telehealth and Remote Counseling

The trend of telehealth and remote counseling is gaining prominence in the Direct-to-Consumer (DTC) Genetic Testing Market, addressing the challenge of genetic counseling accessibility. Companies are leveraging digital platforms to provide consumers with convenient access to genetic counseling services remotely. This ensures that individuals receive guidance and support in interpreting complex genetic test results from the comfort of their homes. The integration of telehealth not only enhances the overall consumer experience but also promotes informed decision-making. By embracing remote counseling, DTC genetic testing services are bridging the gap between consumers and genetic expertise, making genetic information more accessible and understandable.

Segmental Insights

Test Type Insights

Basedon the test type, ancestry and relationship testing emerged as the fastest growing segment in the Global Direct-to-Consumer (DTC) Genetic Testing Market due to its broad consumer appeal and non-medical nature. This category provides insights into one's heritage, family origins, and connections with relatives, appealing to a diverse consumer base interested in exploring their ancestral roots. The allure of genealogy, family history, and discovering genetic relatives greatly fuels the popularity of Ancestry and Relationship Testing. This non-clinical emphasis aligns with the increasing trend of consumers seeking a comprehensive understanding of their genetic makeup beyond health-related aspects, making it a significantly growing and widely embraced segment in the DTC genetic testing industry.

Technology Insights

Single Nucleotide Polymorphism (SNP) chips dominate the Global Direct-to-Consumer (DTC) Genetic Testing Market due to their efficiency in providing comprehensive genetic insights at an affordable cost. These chips analyze variations in single nucleotides across the genome, offering a cost-effective method for identifying genetic markers associated with various traits, ancestry, and health conditions. The widespread use of SNP chips enables large-scale genotyping, facilitating the generation of extensive genetic data for consumers. This dominance is driven by the balance of accuracy, affordability, and the ability to cover a broad spectrum of genetic information, making SNP chips a preferred choice in the DTC genetic testing landscape.

Regional Insights

North America asserts its dominance in the Global Direct-to-Consumer (DTC) Genetic Testing Market owing to factors such as widespread consumer awareness, favorable regulatory environments, and a robust healthcare infrastructure. The region's tech-savvy population and high disposable income significantly contribute to its substantial market share, as consumers increasingly seek personalized genetic insights. The presence of key market players, active promotion of DTC genetic testing services, and a culture of early technology adoption further bolster North America's leadership position. Collaborative efforts between DTC genetic testing companies and research institutions also enhance the region's status as a hub for genetic testing innovations and advancements.

Key Market Players

23andMe, Inc

Ancestry.com, LLC

Color Health, Inc

Helix, Inc.

Counsyl, Inc.

MyHeritage Ltd.

Living DNA Ltd.

Mapmygenome India Limited

Full Genomes Corporation, Inc

Direct Laboratory Services, LLC

Report Scope:

In this report, the Global Direct-To-Consumer (DTC) Genetic Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Direct-To-Consumer (DTC) Genetic Testing Market,By Test Type:

Direct-To-Consumer (DTC) Genetic Testing Market,By Technology:

Direct-To-Consumer (DTC) Genetic Testing Market,By Sample:

Direct-To-Consumer (DTC) Genetic Testing Market,By Distribution Channel:

Direct-To-Consumer (DTC) Genetic Testing Market, By Region:

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Direct-To-Consumer (DTC) Genetic Testing Market.

Available Customizations:

Global Direct-To-Consumer (DTC) Genetic Testing market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1.Product Overview

2.Research Methodology

3.Executive Summary

4.Global Direct-To-Consumer (DTC) Genetic Testing Market Outlook

5.Asia Pacific Direct-To-Consumer (DTC) Genetic Testing Market Outlook

6.Europe Direct-To-Consumer (DTC) Genetic Testing Market Outlook

7.North America Direct-To-Consumer (DTC) Genetic Testing Market Outlook

8.South America Direct-To-Consumer (DTC) Genetic Testing Market Outlook

9.Middle East and Africa Direct-To-Consumer (DTC) Genetic Testing Market Outlook

10.Market Dynamics

11.Market Trends Developments

12.Global Direct-To-Consumer (DTC) Genetic Testing Market: SWOT Analysis

13.Porter's Five Forces Analysis

14.Competitive Landscape

15.Strategic Recommendations

16.About Us Disclaimer

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기